CD274 and cancer: Among the recently investigated treatments, we found that Talimogene, an oncolytic immunotherapy (used for unresectable melanoma) PD-1/PD-L1 axis inhibitor, showed efficacy in treating Merkel cell carcinoma (a virus-induced cancer, similar to KS) and is now a target for a phase II clinical trial in classic KS.